Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments

• Shelli Schomaker,

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Drug Safety R&D, Pfizer, Inc, Groton, CT, United States of America

  ⨯
• David Potter,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Drug Safety R&D, Pfizer, Inc, Groton, CT, United States of America

  ⨯
• Roscoe Warner,

  Roles Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation University of Michigan, Ann Arbor, MI, United States of America

  ⨯
• Jane Larkindale,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Critical Path Institute, Tucson, AZ, United States of America

  ⨯
• Nicholas King,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Critical Path Institute, Tucson, AZ, United States of America

  http://orcid.org/0000-0003-0063-2617

  ⨯
• Amy C. Porter,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Critical Path Institute, Tucson, AZ, United States of America

  ⨯
• Jane Owens,

  Roles Data curation, Formal analysis

  Affiliation Rare Disease Research Unit, Pfizer, Inc, Cambridge, MA, United States of America

  ⨯
• Lindsay Tomlinson,

  Roles Data curation, Formal analysis

  Affiliation Drug Safety R&D, Pfizer, Inc, Groton, CT, United States of America

  ⨯
• John-Michael Sauer,

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Critical Path Institute, Tucson, AZ, United States of America

  ⨯
• Kent Johnson,

  Roles Conceptualization, Formal analysis, Writing – original draft

  Affiliation University of Michigan, Ann Arbor, MI, United States of America

  ⨯
• Jiri Aubrecht

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  * E-mail: Jiri.Aubrecht@takeda.com

  Current address: Takeda Pharmaceuticals, Cambridge, MA, United States of America

  Affiliation Drug Safety R&D, Pfizer, Inc, Groton, CT, United States of America

  http://orcid.org/0000-0003-4304-2430

  ⨯